Reisch N — Endo Lab

2026

Once-daily, late-night, modified-release hydrocortisone rapidly normalizes menstrual cyclicity in women with non-classic congenital adrenal hyperplasia.

Human reproduction open ·doi:10.1093/hropen/hoag071

Study questionDoes late-night, modified-release hydrocortisone (MR-HC) improve biochemical control and restore menstrual regularity in women with non-classic congenital adrenal hyperplasia (NCCAH)?Summary answerOnce-daily MR-HC substantiall…

2022

11-Oxygenated androgens are not secreted by the human ovary: in-vivo data from four different cases of hyperandrogenism.

European journal of endocrinology ·doi:10.1530/eje-22-0518

ObjectiveDifferentiation of an adrenal from an ovarian source of hyperandrogenemia can be challenging. Recent studies have highlighted the importance of 11-oxygenated C19 steroids to the androgen pool in humans. The aim of this study was to…

2020

MON-177 CAH-X Syndrome in a German Cohort of Patients with Congenital Adrenal Hyperplasia

Journal of the Endocrine Society

Abstract Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) is encoded by the CYP21A2 gene. The CYP21A2 gene is flanked and partially overlapped by the TNXB gene encoding an extracellular matrix protein called Tenascin-X.…